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Method for delivering drugs soluble in a vaporization vehicle
Abstract
This invention relates to a method for delivering drugs sublimable in a vaporization vehicle. The method
involves combining a sufficient amount of a vaporization vehicle to sublime the drug and the drug to be
delivered, heating the vaporization vehicle to substantially its boiling point and administering the vapor by
inhalation to a subject.
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METHOD FOR DELIVERING DRUGS 
SOLUBLE IN A VAPORIZATION VEHICLE 
BACKGROUND OF THE INVENTION 
1. Field of the Invention 
This invention relates to a method for delivering drugs 
soluble in a vaporization vehicle. More particularly, this 
invention relates to a method for delivering soluble volatil 
izing drugs to subjects. The present method can be charac 
terized by rapid site respiratory speci?c delivery of the drug. 
2. Description of the Prior Art 
In general the prior art relates to means for delivering 
drugs in the form of very small liquid drops. These means 
include ultrasonic nebulization, vortex jet nebulization, and 
vacuum entrainment. In these instances the drugs are deliv 
ered as an aerosol. See e.g. Fisinin et al., U.S. Pat. No. 
4,947,802. Certain prior art documents show a preheater for 
nebulizing a liquid, but this heating process is not designed 
to vaporize the drug. See e.g. Weiler et al., US. Pat. No. 
4,95 1,695. 
Additional prior methods to deliver drugs involve simply 
adding the drugs to water or feed. Both types of prior drug 
delivery methods suffer from the same drawback in that high 
levels of drug residues become incorporated into the ani~ 
mal’s tissue and then will be subsequently consumed in the 
animal meat. As such a need exists in the industry to develop 
a drug delivery system that is e?’ective without these harmful 
side effects. 
SUMMARY OF THE INVENTION 
This invention provides a process for delivering drugs to 
a subject characterized by the steps of: a) combining a 
su?icient amount of a vaporization vehicle to solubilize the 
drug and a drug to be delivered; b) heating the vaporization 
vehicle to substantially its boiling point; and administering 
the vapor by inhalation to the subject. The drugs to be used 
in this process include sulfamethazine, sulfamethoxazole, 
sulfadimethoxine and gentamicin. These drugs volatilize at 
a temperature between about 180° to 200° C. and are 
administered for up to 5 minutes to obtain 0.2 ppm in a 
subject’s blood. In the preferred embodiment, the vaporiza 
tion vehicle is a terpene such as menthol, carvone, methone, 
or camphor. 
The invention also provides a process for delivering drugs 
soluble to a subject characterized by the steps of: a) com 
bining a sui?cient amount of terpene to solubilize a drug and 
a drug to be administered; b) heating the terpene to sub 
stantially its boiling point; and administering the vapor by 
inhalation to the subject. The drugs to be used in this process 
include sulfamethazine, sulfamethoxazole, sulfadimethox 
inc and gentamicin. These drugs volatilize between 180° to 
200° C. and are administered for up to 5 minutes to obtain 
0.2 ppm in a subject’s blood. In the preferred embodiment, 
the vaporization vehicle is a terpene such as menthol, 
carvone, methone or camphor. 
BRIEF DESCRIPTION OF THE DRAWINGS 
FIG. 1 shows a schematic drawing of a drug delivery 
apparatus. 
DETAILED DESCRIPTION OF THE 
INVENTION 
This method provides a means of administering the drug 
deep into the lungs and into the blood stream almost 
instantaneously. This method does not create the high levels 
of sulfa residues in meat like the previously discussed prior 
art methods. 
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Now referring to FIG. 1, a schematic drawing of a drug 
delivery apparatus is shown. To begin, a volatile chamber 1 
which can allow for visual observation of the drug and 
vehicle is used. A thermometer 2 is placed on the inside 
surface of the volatile chamber 1 where the outside surface 
is being heated by heater 3. At the top of the volatile 
chamber, there is one inlet 4 and one exhaust opening 5. 
These openings have valves 6 and 7 on them. The inlet valve 
6 is air tight, where the exhaust valve 7 is obstructive but not 
air tight. Both of these valves 6 and 7 should open at the 
same time with a single action opening device. The inlet 
valve 6 allows low pressure air to flow into the volatile 
chamber 1 and out the exhaust valve 7 carrying the treated 
air. The air is pressurized by air pump 10. The exhaust tube 
8 enters treatment chamber 9 which restricts the air ?ow that 
passes from the volatile chamber 1, by inlet hole 13. Animals 
are placed into treatment chamber 9 through door 12. 
The present invention is directed to a method of deliver 
ing volatile drugs for treatment of domestic animals or 
mammals using the above described instrument. More spe 
ci?cally, the invention is directed to a method of volatilizing 
drugs at temperatures below their boiling point. This objec 
tive is achieved by volatilizing the drug in the presence of a 
vaporization vehicle as the vehicle sublimes. The vaporiza 
tion vehicle is a compound which sublimes and causes the 
drug to volatilize below its boiling point. The vaporization 
vehicle allows the volatilization of the drug at temperatures 
below its normal melting point. 
This concept was originally tested with equal parts of 
sulfamethazine and menthol in the vapor chamber. Sul 
famethazine has a melting point of 176° to 207° C. It should 
be noted that boiling points of compounds are usually 
l50°—200° C. higher than most melting points. Using men~ 
thol as a vaporization vehicle, however sulfamethazine will 
volatilized between 180°-200° C., which is a temperature 
closer to its melting point. This occurred because the vapor 
ization vehicle (menthol) has a melting point of between 41° 
to 43° C. and a boiling point of 212° Cv so as the compounds 
mix the vaporization vehicle carries the sulfamethazine into 
the air as it reaches its boiling point. 
Drug treatment levels achieved via volatilization have 
been found by the present inventors to be higher than oral 
treatment levels. Moreover, when the drug is administered 
according to the present method the drug is delivered to 
blood and speci?c organs, while with conventional water 
delivery the drug is found throughout the animal. Speci?' 
cally, drug levels were attained that were twice the amount 
previously obtained from the oral intake of the drug in water. 
The oral intake was systemic, but caused higher drug 
residues in the meat. The critical factor with this inhalation 
therapy is limited contact time, since the lungs inhale and 
exhale. Tests revealed that once the treatment is stopped, 
twenty ?ve minutes later only half the level of sulfa can be 
detected. 
The results of sulfamethazine inhalation therapy in lung 
tissue show that if taken orally, (dissolved in water) the 
results were 0.1 ppm (parts per million). But if taken through 
inhalation the immediate levels were 0.2 ppm and were 
reduced to 0.1 ppm twenty ?ve minutes later. The levels that 
were taken orally were administered for a period of time on 
the order of days, while inhalation treatments were for a 
period of time on the order of minutes in length (?ve 
minutes). 
The present method is capable of volatilizing drugs such 
as sulfamethazine, sulfamethoxazole, sulfadimethoxine, and 
gentamicin. All of these drugs volatilize between 180°-200° 
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C. with this method. The amount of vaporization vehicle 
depends on which drug is delivered. More speci?cally, if 
menthol is the vaporization vehicle about 0.5 grams of 
sulfamethoxazole solubilizes in 0.125 grams of menthol, 
while 0.5 grams of sulfamethazine solubilize in 0.250 grams 
of menthol. Certain drugs such as gentamicin can be vola 
tilized with little or no menthol. Generally, the proportions 
of the drug to the volatilizing vehicle are determined experi 
mentally with equal parts of the volatilizing vehicle such as 
menthol with about ?ve grams of drugs as the starting point 
for ascertaining the proportions. Other potential vaporiza 
tion vehicles include carvone, menthone and carnphor. 
This method for example may be useful in the treatment 
of bordetella avium disease in turkeys. The two drugs that 
have been successful at treating the disease, are capable of 
being volatilized. These are gentarrricin and sulfamethox 
azole. 
Example 1 
Tests were conducted to study the entry of sulfa drugs into 
the blood and lungs of test subjects. Referring now to FIG. 
1 heater 3 was activated to a predetermined setting. Samples 
of sulfamethazine and menthol (0.285 grams equal portions 
of each) were weighed and heated to 180° C. in a distillation 
?ask in the volatile chamber 1. Rats were placed in the 
treatment chamber 9. The lid to the treatment chamber 9 had 
an inlet hole 13 connected to a tube 8 from exhaust outlet 5 
of the volatile chamber 1. 
An air pump was used to circulate air through the volatile 
chamber 10 to the treatment chamber. The rats’ condition, 
temperature of the ?ask and vapor ?ow into the treatment 
chamber 9 were monitored. After three minutes of inhalation 
therapy the air ?ow was shut off and the rats were removed 
from treatment chamber 9. 
Blood and lung tissue were removed for testing. The 
results are shown in Table 1. 
TABLE 1 
Delivery of Sulfamethazine 
Rat #7 Lungs:NDA* Rat #8 LungszNDA 
BloodzNDA BloodzNDA 
Rat #9 LungszNDA Rat #10 LungszTrace 
Bloodzl ppm Bloodzl ppm 
Rat #11 LungszTrace Rat #12 LungszTrace 
Bloodzl ppm Bloodzl ppm 
Rat #13 LungszNDA Rat #14 LungszNDA 
Blood:l ppm Blood:0.1 ppm 
Rat #15 LungsINDA Rat #16 Lungs:NDA 
Blood:0.l ppm B1ood:0.2 ppm 
Rat #17 LungszTrace Rat #18 LungszTrace 
'0.1 ppm "0.1 ppm 
Blood:0.2 ppm Blood:0.2 ppm 
*No detectable amount 
Example 2 
Tests were conducted to study the entry of sulfa drugs into 
the blood and lungs of test subjects. Referring now to FIG. 
1 heater 3 was activated to a predetermined setting. Samples 
of sulfamethazine and menthol (0.285 grams equal portions 
of each) were weighed and heated at 180° C. in a distillation 
?ask in the volatile chamber. Rats were placed in the 
treatment chamber 9. The lid to the treatment chamber 9 had 
an inlet hole 13 connected to a tube 8 from exhaust outlet 5 
of the volatile chamber 1. 
An air pump was used to circulate air through the volatile 
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chamber 10 to the treatment chamber. The rats’ condition, 
temperature of the ?ask and vapor ?ow into the treatment 
chamber 9 were monitored. After three minutes of inhalation 
therapy the air ?ow was shut oil’ and the rats were removed 
from treatment chamber 9. Blood and lung tissue were 
removed for testing. The results are shown in Table 2. 
TABLE 2 
Delivery of Sulfamethazine 
Rats # Tissue Lungs Blood 
1, 2, 3, 4 NDA NDA NDA 
5 NDA 30 ppb NDA 
6 Trace 50 ppb NDA 
7 NDA 50 ppb 50 ppb 
8 NDA 100 ppb 50 ppb 
9 NDA 50 ppb 150 ppb 
10 NDA 25 ppb 150 ppb 
11 NDA 50 ppb 50 ppb 
12 NDA Trace 100 ppb 
13 NDA Trace NDA 
Example 3 
A test was conducted to study the volatility of sul 
famethoxazole when suspended as a vapor into the air of the 
volatile and treatment chamber. Air samples were taken to 
determine the levels of sulfamethoxazole. Referring now to 
FIG. 1 heater 3 was activated to the predetermined setting. 
Samples of sulfamethoxazole and menthol (0.285 grams 
equal portions of each) were weighed and heated to 180° C. 
in a distillation ?ask or volatile chamber. Once the samples 
started to change chemical state from solid to a liquid air 
sample #1 was taken directly above the material. Air sample 
#2 was taken at the same time but higher up in the volatile 
chamber. The volatile chamber was then subjected to the air 
?ow source. At 30 seconds air sample #3 was taken from the 
middle of the treatment chamber and again at the 1 minute 
point air sample #4 was taken from the treatment chamber. 
At this time the entire treatment chamber was visually ?lled 
with the vapor. The results, are shown in Table 3. 
TABLE 3 
Delivery of sulfamethoxazole 
Sample # Results 
Air 1 5 pg 
Air 2 NDA 
Air 3 NDA 
Air 4 2.5 pg 
Swab 1 10 pg 
Swab 2 10 pg 
Standards 5, l0, & 20 pg 
Although the invention has been described primarily in 
connection with special and preferred embodiments, it will 
be understood that it is capable of modi?cation without 
departing from the scope of the invention. The following 
claims are intended to cover all variations, uses or adapta 
tions of the invention, following, in general, the principles 
thereof and including such departures from the present 
disclosure as come within known or customary practice in 
the ?eld to which the invention pertains, or as are obvious 
to persons skilled in the ?eld. 
We claim: 
1. A method for delivering a drug soluble in a vaporization 
vehicle to a subject, the method comprising the steps of: 
5,456,247 
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a) combining a su?icient amount of a vaporization vehicle 
selected from the group consisting of: menthol, car 
vone, menthone and camphor to solubilize a drug 
selected from the group consisting of: sulfamethazine, 
sulfarnethoxazole, sulfadimethoxine and gentamicin 5 
and a drug to be delivered; 
b) heating said vaporization vehicle to substantially its 
boiling point; and 
c) administering said vapor by inhalation to said subject. 
2. The method of claim 1 wherein said drugs volatilize 
between about 180° to 200° C. A“ 
3. The method of claim 1 wherein said drugs are admin 
istered for up to 5 minutes to obtain 0.2 ppm in subject 
blood. 
4. The method of claim 1 wherein the vaporization vehicle 
is a terpene. 
5. A method for delivering a drug soluble in a terpene to 
a subject, the method comprising the steps of: 
6 
a) combining a su?icient amount of a terpene to solubilize 
a drug selected from the group consisting of: sulfamet 
hazine, sulfamethoxazole, sulfadimethoxine and gen 
tamicin and a drug to be delivered; 
b) heating said terpene to substantially its boiling point; 
and 
c) administering said vapor by inhalation to said subject. 
6. The method of claim 5 wherein said drugs volatilize 
10 between about 180° to 200° C. 
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7. The method of claim 5 wherein said drugs are admin 
istered for up to 5 minutes to obtain 0.2 ppm in a subject’s 
blood. 
8. The method of claim 5 wherein the terpene is selected 
from the group consisting of: menthol, carvone, menthone, 
and camphor. 
